Amicus Therapeutics (FOLD)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.90 +0.09 (+1.02%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.90 unch (unch) 16:03 ET
for Fri, Mar 14th, 2025
Results
download Want to compare other data? Select FieldsSymbol | FOLD | HCM | XENE | ||
Company | Amicus Therapeutics | Hutchmed China Ltd ADR | Xenon Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 8.87 | 15.68 | 35.20 | ||
High | 9.00 | 15.71 | 36.25 | ||
Low | 8.79 | 15.49 | 35.15 | ||
Last | 8.90 | 15.69 | 35.32 | ||
Change | +0.09 | +0.32 | +0.14 | ||
% Change | +1.02% | +2.08% | +0.40% | ||
Volume | 1,804,000 | 49,900 | 270,900 | ||
20-Day Average Volume | 2,579,610 | 84,360 | 523,595 | ||
Previous Close | 8.81 | 15.37 | 35.18 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 9.15 | 15.69 | 37.19 | ||
20-Day Raw Stochastic | 24.40% | 60.29% | 30.46% | ||
20-Day Relative Strength | 42.47% | 52.78% | 40.26% | ||
Weighted Alpha | -23.91 | -13.06 | -21.47 | ||
Today's Opinion | 100% Sell | 48% Sell | 88% Sell | ||
Previous Opinion | 100% Sell | 56% Sell | 88% Sell | ||
Last Month's Opinion | 88% Sell | 100% Sell | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.45% since 03/07/25 | -5.08% since 03/07/25 | -3.23% since 03/07/25 | ||
Low | 8.55 on 03/10/25 | 15.13 on 03/13/25 | 33.81 on 03/11/25 | ||
High | 9.00 on 03/14/25 | 15.76 on 03/11/25 | 36.86 on 03/10/25 | ||
1-Month | |||||
%Chg | -8.90% since 02/14/25 | +13.70% since 02/14/25 | -9.23% since 02/14/25 | ||
Low | 8.55 on 03/10/25 | 13.58 on 02/18/25 | 33.27 on 02/28/25 | ||
High | 10.00 on 02/19/25 | 17.08 on 02/27/25 | 40.00 on 02/26/25 | ||
3-Month | |||||
%Chg | -4.91% since 12/13/24 | +0.71% since 12/13/24 | -11.81% since 12/13/24 | ||
Low | 8.55 on 03/10/25 | 12.84 on 02/12/25 | 33.27 on 02/28/25 | ||
High | 10.00 on 02/19/25 | 17.08 on 02/27/25 | 42.23 on 01/02/25 | ||
6-Month | |||||
%Chg | -21.24% since 09/13/24 | -9.25% since 09/13/24 | -13.52% since 09/13/24 | ||
Low | 8.55 on 03/10/25 | 12.84 on 02/12/25 | 33.27 on 02/28/25 | ||
High | 12.65 on 11/06/24 | 21.50 on 10/23/24 | 46.00 on 11/08/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 2,734,436 | 2,735,081 | 2,703,499 | ||
Shares Outstanding, K | 307,240 | 174,320 | 76,543 | ||
Annual Sales | 528,300,000 | 838,000,000 | 0 | ||
Annual Net Income | -56,110,000 | 100,780,000 | -234,330,000 | ||
Last Quarter Sales | 149,710,000 | 75,806,000 | 0 | ||
Last Quarter Net Income | 14,740,000 | -61,254,000 | -65,690,000 | ||
60-Month Beta | 0.69 | 0.77 | 1.26 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.09 on 02/19/25 | N/A on 07/28/21 | -0.84 on 02/27/25 | ||
Latest Earnings Date | 05/08/25 | 03/19/25 | 05/08/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 146.83 | 0.00 | 0.00 |